Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT01740258
Status:
COMPLETED
Last Update Posted:
2021-01-26
First Post:
2012-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab Beyond Progression (BBP)
Sponsor:
Duke University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-01
Start Date Type:
ACTUAL
Primary Completion Date:
2019-11-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-11-14
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-30
First Submit QC Date:
None
Study First Post Date:
2012-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-11-06
Results First Submit QC Date:
None
Results First Post Date:
2020-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-06
Last Update Post Date:
2021-01-26
Last Update Post Date Type:
ACTUAL